In a recent New Yorker article about potential medical uses for psilocybin (“The Trip Treatment”), science, culture, and food writer Michael Pollan interviewed researchers in neuroscience, medicine, and psychology. The medical potential of psychedelic drugs is not something I can comment on from reading just one article; what intrigued me most about this piece is how these drug studies overlap with studies on cognition, metacognition, consciousness, and spirituality. The medically-controlled “tripping” that volunteers have undergone overwhelmingly resulted in some form of what we term mystical or spiritual (for lack of a scientific term) feeling.
It’s almost impossible to consider these realms of experience without questioning concepts such as “soul” or “self-awareness.” Pollan writes:
Roland Griffiths is willing to consider the challenge that the mystical experience poses to the prevailing scientific paradigm. He conceded that “authenticity is a scientific question not yet answered” and that all that scientists have to go by is what people tell them about their experiences. But he pointed out that the same is true for much more familiar mental phenomena.
“What about the miracle that we are conscious? Just think about that for a second, that we are aware we’re aware!”
A man after my own heart. It is amazing, a kind of miracle. And we get consciousness and metacognition without any drug intervention at all. It just springs into our beings at some point, as we create ourselves from lived events and construct speculative worlds and an understanding (though often flawed) of other minds.
Here is another fascinating result from the psilocybin studies that may make us revise our ideas of interpersonal relationships, personhood, and creating a self. Pollan writes:
A follow-up study by Katherine MacLean, a psychologist in Griffiths’s lab, found that the psilocybin experience also had a positive and lasting effect on the personality of most participants. This is a striking result, since the conventional wisdom in psychology holds that personality is usually fixed by age thirty and thereafter is unlikely to substantially change. But more than a year after their psilocybin sessions volunteers who had had the most complete mystical experiences showed significant increases in their “openness,” one of the five domains that psychologists look at in assessing personality traits. (The others are conscientiousness, extroversion, agreeableness, and neuroticism.) Openness, which encompasses aesthetic appreciation, imagination, and tolerance of others’ viewpoints, is a good predictor of creativity. [italics mine]
Openness, aesthetic appreciation, imagination, tolerance, creativity…and one researcher in neuropsychopharmacology suggests that this sort of un-boundaried openness signifies a temporary regression to an infantile state, very much as Freud hypothesized. I thought instead of Bachelard and the childhood reverie state.
Intriguing, that pharmacological work of this sort makes neuroscientists resort to citing William James and Sigmund Freud on mystical experience and the subconscious!
[Robin] Carhart-Harris believes that people suffering from other mental disorders characterized by excessively rigid patterns of thinking, such as addiction and obsessive-compulsive disorder, could benefit from psychedelics, which “disrupt stereotyped patterns of thought and behavior.” In his view, all these disorders are, in a sense, ailments of the ego. He also thinks that this disruption could promote more creative thinking. It may be that some brains could benefit from a little less order. [italics mine]
I wonder if the aesthetic experience itself, when wholly engaged, can sometimes act like a drug on the art-viewer’s or art-maker’s being. When one reads the poem that rearranges one’s world, doesn’t it disrupt stereotyped, familiar, habitual patterns of thought? That’s what happens for me when I encounter great art of any kind. It is close to mystical.